CIBC Bancorp USA
RVMD icon

CIBC Bancorp USA’s Revolution Medicines RVMD Stock Holding History

CIBC Bancorp USA’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$28M Buy
136,615
+69,364
+103% +$13.7M 0.04% 349
2026
Q2 		$12.6M Buy
67,251
+52,987
+371% +$7.74M 0.02% 500
2026
Q1 		$1.39M Buy
+14,264
New +$1.44M ﹤0.01% 979

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

CIBC Bancorp USA's RVMD Position: Q3 2026 in Review

CIBC Bancorp USA increased its Revolution Medicines (RVMD) stake by 103% in Q3 2026, buying an estimated $13.7M and bringing the position to 136,615 shares worth $28M. The position accounts for 0.04% of the portfolio, ranked #349.

CIBC Bancorp USA first reported a position in RVMD in Q1 2026 and has held it in 3 quarters since. 577 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • CIBC Bancorp USA held 136,615 shares of Revolution Medicines worth $28M as of Q3 2026.
  • CIBC Bancorp USA bought 69,364 Revolution Medicines shares in Q3 2026, an estimated $13.7M.
  • Revolution Medicines made up 0.04% of CIBC Bancorp USA's portfolio in Q3 2026, its #349 holding.
  • CIBC Bancorp USA first reported a position in Revolution Medicines in Q1 2026 and has held it in 3 quarters since.
  • 577 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.